Ironwood Pharmaceuticals Inc

Connor, Clark & Lunn Investment Management Ltd. IRWD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

1,990,927

Value ($000)

6,709

Weight

0.0%

2022 Q4 - 2025 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	6,709	0.0%	1,990,927	12/31/2025
2025 Q3	11/13/2025	2,832	0.0%	2,161,818	9/30/2025
2025 Q2	8/7/2025	1,583	0.0%	2,206,948	6/30/2025
2025 Q1	5/12/2025	2,187	0.0%	1,488,044	3/31/2025
2024 Q4	2/10/2025	1,513	0.0%	341,455	12/31/2024
2024 Q3	11/8/2024	520	0.0%	126,289	9/30/2024
2024 Q2	8/9/2024	328	0.0%	50,372	6/30/2024
2023 Q4	2/9/2024	3,474	0.0%	303,675	12/31/2023
2023 Q3	11/13/2023	4,822	0.0%	500,681	9/30/2023
2023 Q2	8/10/2023	5,329	0.0%	500,817	6/30/2023
2023 Q1	5/10/2023	5,181	0.0%	492,524	3/31/2023
2022 Q4	2/10/2023	3,749	0.0%	302,565	12/31/2022